Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nadia Benny
Institution:
The Ohio State University Wexner Medical Center
Observed institution:
The Ohio State University Wexner Medical Center
ORCID:
0009-0002-3654-0191
Observed ORCID:
0009-0002-3654-0191
OpenAlex ID:
A5116058005
Supplemental Figure S1 from The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial
2026
·
Leigha Senter
, Shelly Hovick
, et al.
Supplemental Materials S2 from The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial
2026
·
Leigha Senter
, Shelly Hovick
, et al.
Supplemental Table S5 from The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial
2026
·
Leigha Senter
, Shelly Hovick
, et al.
Supplemental Table S2 from The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial
2026
·
Leigha Senter
, Shelly Hovick
, et al.
Supplemental Table S1 from The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial
2026
·
Leigha Senter
, Shelly Hovick
, et al.
Supplemental Materials S1 from The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial
2026
·
Leigha Senter
, Shelly Hovick
, et al.
Supplemental Table S4 from The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial
2026
·
Leigha Senter
, Shelly Hovick
, et al.
Supplemental Table S6 from The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial
2026
·
Leigha Senter
, Shelly Hovick
, et al.
Supplemental Table S3 from The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial
2026
·
Leigha Senter
, Shelly Hovick
, et al.
Data from The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial
2026
·
Leigha Senter
, Shelly Hovick
, et al.
The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial
2026
·
Leigha Senter
, Shelly Hovick
, et al.
·
Cancer Prevention Research
Show more works
View as search
Works count:
11
Citation count:
H-index:
I10-index:
Year
Topic
Type